Modelling the Impact of Persistence Improvements With an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.855
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
Elsevier BV